Time-Restricted Eating for Weight Loss Maintenance
(TWIST-2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether time-restricted eating (TRE), where eating occurs within a 10-hour window each day, can help maintain weight loss and prevent fat gain. Researchers are also examining how TRE affects hunger after meals. Participants will either follow the TRE method or receive standard advice on maintaining weight. Ideal candidates have lost at least 5% of their body weight in the last three months, have a current BMI between 20.5 and 45, and are open to using a smartphone for tracking. As an unphased trial, this study offers participants the opportunity to contribute to innovative research on weight management strategies.
Will I have to stop taking my current medications?
The trial requires that participants not take medications that affect body weight or would interfere with time-restricted eating. If you're on such medications, you may need to stop them to participate.
What prior data suggests that time-restricted eating is safe for weight loss maintenance?
Research has shown that time-restricted eating (TRE) is generally safe for participants. In studies involving people with obesity, TRE resulted in a weight loss of about 3%–5% over 2–12 months. These studies not only assess TRE's effectiveness but also indicate it is well-tolerated without major safety issues.
Moreover, other studies have found improvements in health markers, such as insulin levels, without significant negative effects. This suggests that TRE does not cause serious side effects for most people.
Overall, current evidence suggests that TRE is a safe option for managing weight. However, individual experiences may differ, so consulting a healthcare provider about any concerns is advisable.12345Why are researchers excited about this trial?
Researchers are excited about time-restricted eating (TRE) for weight loss maintenance because it offers a fresh approach compared to traditional calorie-counting diets. TRE involves limiting eating to a specific window of time each day—typically 10 hours or less—without strictly focusing on what or how much you're eating. This method may help regulate metabolism and improve overall health by aligning eating patterns with the body's natural circadian rhythms. Unlike typical diets that can be hard to stick to, TRE might be easier to maintain, making it an appealing option for long-term weight management.
What evidence suggests that time-restricted eating is effective for weight loss maintenance?
This trial will compare Time-Restricted Eating (TRE) with a Baseline Advice Control (CON) for weight loss maintenance. Research has shown that TRE can aid in weight loss and body fat reduction. For individuals with obesity, TRE has resulted in a 3%–5% weight loss over 2 to 12 months compared to those not using TRE. Some studies suggest that eating earlier in the day with TRE is more effective for losing weight and fat. However, not everyone experiences weight loss with TRE, especially if they consume the same or more calories than before. Overall, TRE might help maintain recent weight loss, but results can vary from person to person.12467
Who Is on the Research Team?
Collin Popp
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
Adults aged 25-65 who've lost at least 5% of their weight in the past 3 months, have a BMI between 20.5 and 45, and can use a smartphone for self-monitoring are eligible. Those pregnant, breastfeeding, with eating disorders, on weight-affecting meds or doing shift work more than once weekly cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Run-in
4-week run-in period to establish weight stabilization and measure eating patterns before randomization
Treatment
Participants are randomized to either the TRE intervention or the CON group, with measurements at baseline, 6 months, and 12 months
Follow-up
Participants are monitored for weight and fat mass changes using DEXA scans and subjective appetite changes
What Are the Treatments Tested in This Trial?
Interventions
- TRE
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator